CLEVELAND, Ohio, Oct. 29, 2008 (GLOBE NEWSWIRE) -- Athersys, Inc. (Nasdaq:ATHX) today announced it has been selected by Frost & Sullivan to receive the 2008 North American Product Innovation of the Year Award. The Company was selected in recognition of its novel stem cell product, MultiStem(r), a therapeutic product candidate in clinical and preclinical development for multiple disease indications, including the treatment of cardiovascular disease, cancer, ischemic stroke, and a range of other conditions involving ischemic injury or immune system function.
